LOH, TAIs, and LSTs were shown to correlate well with mutations in HR genes BRCA1/2 in breast and ovarian cancer (Abkevich et al. 2012; Birkbak et al. 2012; Popova et al. 2012). The gene discussed is BRCA1; the disease is ovarian carcinoma.